Skip to main content
Top
Published in:

Open Access 01-12-2024 | Original Article

Value of high frame rate contrast-enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma

Authors: Xiang Fei, Lianhua Zhu, Peng Han, Bo Jiang, Miao Li, Nan Li, Ziyu Jiao, Dirk-André Clevert, Yukun Luo

Published in: Insights into Imaging | Issue 1/2024

Login to get access

Abstract

Objectives

To investigate the value of vascular morphology on high frame rate contrast-enhanced ultrasound (H-CEUS) and CEUS Li-RADS in predicting microvascular invasion (MVI), Ki-67 expression and recurrence of hepatocellular carcinoma (HCC).

Methods

This retrospective study enrolled 78 patients with single HCC diagnosed by postoperative pathology between January 1, 2021, and June 30, 2022. All patients underwent ultrasound and H-CEUS examination before operation. H-CEUS image features and CEUS Li-RADS were compared in different MVI status and Ki-67 level. Multiple logistic regression analysis was performed to select independent variables for MVI. Differences in recurrence among different H-CEUS image features, MVI status and Ki-67 level were further analyzed.

Results

Tumor shape, vascular morphology, LR-M category, necrosis and AFP level were different between the MVI-positive group and MVI-negative group (p < 0.05). Vascular morphology and LR-M category were independent risk factors related to MVI (p < 0.05). Vascular morphology was also different between the high Ki-67 expression group and low Ki-67 expression group (p < 0.05). Vascular morphology, MVI status and Ki-67 expression were different between the recurrence group and no recurrence group (p < 0.05).

Conclusion

The vascular morphology of HCC on H-CEUS can indicate the risk of MVI status, Ki-67 expression and recurrence, which provides a feasible imaging technique for predicting the prognosis before operation.

Critical relevance statement

H-CEUS shows the different vascular morphology of HCC in arterial phase and indicates the risk of MVI, Ki-67 expression and recurrence, which provides a feasible imaging technique for clinician to judge the risk of MVI pre-operation and adopt appropriate treatment.

Key Points

  • H-CEUS can clearly show different vascular morphology of HCC in arterial phase.
  • Vascular morphology on H-CEUS is associated with MVI status, Ki-67 expression and HCC recurrence.
  • Preoperative MVI and Ki-67 expression prediction could help surgeons choose a more appropriate treatment plan.

Graphical Abstract

Literature
3.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRefPubMed
4.
go back to reference Asrani SK, Devarbhavi H, Eaton J, Kamath PS (2019) Burden of liver diseases in the world. J Hepatol 70:151–171CrossRefPubMed Asrani SK, Devarbhavi H, Eaton J, Kamath PS (2019) Burden of liver diseases in the world. J Hepatol 70:151–171CrossRefPubMed
5.
go back to reference McGlynn KA, Petrick JL, London WT (2015) Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 19:223–238CrossRefPubMedPubMedCentral McGlynn KA, Petrick JL, London WT (2015) Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 19:223–238CrossRefPubMedPubMedCentral
6.
go back to reference Cascales-Campos P, Martinez-Insfran LA, Ramirez P et al (2018) Liver transplantation in patients with hepatocellular carcinoma outside the Milan criteria after downstaging: is it worth it? Transplant Proc 50:591–594CrossRefPubMed Cascales-Campos P, Martinez-Insfran LA, Ramirez P et al (2018) Liver transplantation in patients with hepatocellular carcinoma outside the Milan criteria after downstaging: is it worth it? Transplant Proc 50:591–594CrossRefPubMed
7.
go back to reference Xia YX, Zhang F, Li XC et al (2021) Surgical treatment of primary liver cancer: a report of 10 966 cases. Zhonghua Wai Ke Za Zhi 59:6–17PubMed Xia YX, Zhang F, Li XC et al (2021) Surgical treatment of primary liver cancer: a report of 10 966 cases. Zhonghua Wai Ke Za Zhi 59:6–17PubMed
8.
go back to reference Dong Y, Qiu Y, Yang D et al (2021) Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma. Clin Hemorheol Microcirc 77:461–469CrossRefPubMed Dong Y, Qiu Y, Yang D et al (2021) Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma. Clin Hemorheol Microcirc 77:461–469CrossRefPubMed
9.
go back to reference Takuma Y, Takabatake H, Morimoto Y et al (2013) Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria. Radiology 269:927–937CrossRefPubMed Takuma Y, Takabatake H, Morimoto Y et al (2013) Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria. Radiology 269:927–937CrossRefPubMed
10.
go back to reference Yamakado K, Nakatsuka A, Takaki H et al (2008) Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 247:260–266CrossRefPubMed Yamakado K, Nakatsuka A, Takaki H et al (2008) Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 247:260–266CrossRefPubMed
11.
go back to reference Erstad DJ, Tanabe KK (2019) Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol 26:1474–1493CrossRefPubMed Erstad DJ, Tanabe KK (2019) Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol 26:1474–1493CrossRefPubMed
12.
go back to reference Menyhárt O, Nagy Á, Győrffy B (2018) Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci 5:181006CrossRefPubMedPubMedCentral Menyhárt O, Nagy Á, Győrffy B (2018) Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci 5:181006CrossRefPubMedPubMedCentral
13.
go back to reference Court CM, Harlander-Locke MP, Markovic D et al (2017) Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection. Liver Transpl 23:1123–1132CrossRefPubMed Court CM, Harlander-Locke MP, Markovic D et al (2017) Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection. Liver Transpl 23:1123–1132CrossRefPubMed
14.
go back to reference Nitta H, Allard MA, Sebagh M et al (2019) Prognostic value and prediction of extratumoral microvascular invasion for hepatocellular carcinoma. Ann Surg Oncol 26:2568–2576CrossRefPubMed Nitta H, Allard MA, Sebagh M et al (2019) Prognostic value and prediction of extratumoral microvascular invasion for hepatocellular carcinoma. Ann Surg Oncol 26:2568–2576CrossRefPubMed
15.
go back to reference Li X, Han X, Li L et al (2022) Dynamic contrast-enhanced ultrasonography with sonazoid for diagnosis of microvascular invasion in hepatocellular carcinoma. Ultrasound Med Biol 48:575–581CrossRefPubMed Li X, Han X, Li L et al (2022) Dynamic contrast-enhanced ultrasonography with sonazoid for diagnosis of microvascular invasion in hepatocellular carcinoma. Ultrasound Med Biol 48:575–581CrossRefPubMed
16.
go back to reference Zhu W, Qing X, Yan F, Luo Y, Li Y, Zhou X (2017) Can the contrast-enhanced ultrasound washout rate be used to predict microvascular invasion in hepatocellular carcinoma? Ultrasound Med Biol 43:1571–1580CrossRefPubMed Zhu W, Qing X, Yan F, Luo Y, Li Y, Zhou X (2017) Can the contrast-enhanced ultrasound washout rate be used to predict microvascular invasion in hepatocellular carcinoma? Ultrasound Med Biol 43:1571–1580CrossRefPubMed
17.
go back to reference Hu HT, Wang Z, Huang XW et al (2019) Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma. Eur Radiol 29:2890–2901CrossRefPubMed Hu HT, Wang Z, Huang XW et al (2019) Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma. Eur Radiol 29:2890–2901CrossRefPubMed
18.
go back to reference Yang ZF, Poon RT (2008) Vascular changes in hepatocellular carcinoma. Anat Rec 291:721–734CrossRef Yang ZF, Poon RT (2008) Vascular changes in hepatocellular carcinoma. Anat Rec 291:721–734CrossRef
19.
go back to reference Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 244:898–906CrossRefPubMed Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 244:898–906CrossRefPubMed
20.
go back to reference Fei X, Han P, Jiang B et al (2022) High frame rate contrast-enhanced ultrasound helps differentiate malignant and benign focal liver lesions. J Clin Transl Hepatol 10:26–33CrossRefPubMed Fei X, Han P, Jiang B et al (2022) High frame rate contrast-enhanced ultrasound helps differentiate malignant and benign focal liver lesions. J Clin Transl Hepatol 10:26–33CrossRefPubMed
21.
go back to reference Luo Y, Ren F, Liu Y et al (2015) Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis. Int J Clin Exp Med 8:10235–10247PubMedPubMedCentral Luo Y, Ren F, Liu Y et al (2015) Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis. Int J Clin Exp Med 8:10235–10247PubMedPubMedCentral
22.
go back to reference Yang C, Su H, Liao X et al (2018) Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma. Cancer Manag Res 10:679–696CrossRefPubMedPubMedCentral Yang C, Su H, Liao X et al (2018) Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma. Cancer Manag Res 10:679–696CrossRefPubMedPubMedCentral
23.
go back to reference Huang Z, Zhou P, Li S, Li K (2022) Prediction of the Ki-67 marker index in hepatocellular carcinoma based on dynamic contrast-enhanced ultrasonography with sonazoid. Insights Imaging 13:199CrossRefPubMedPubMedCentral Huang Z, Zhou P, Li S, Li K (2022) Prediction of the Ki-67 marker index in hepatocellular carcinoma based on dynamic contrast-enhanced ultrasonography with sonazoid. Insights Imaging 13:199CrossRefPubMedPubMedCentral
24.
go back to reference Juan MW, Yu J, Peng GX, Jun LJ, Feng SP, Fang LP (2018) Correlation between DCE-MRI radiomics features and Ki-67 expression in invasive breast cancer. Oncol Lett 16:5084–5090PubMedPubMedCentral Juan MW, Yu J, Peng GX, Jun LJ, Feng SP, Fang LP (2018) Correlation between DCE-MRI radiomics features and Ki-67 expression in invasive breast cancer. Oncol Lett 16:5084–5090PubMedPubMedCentral
25.
go back to reference Tanaka H, Iijima H, Higashiura A et al (2014) New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. J Gastroenterol 49:755–763CrossRefPubMed Tanaka H, Iijima H, Higashiura A et al (2014) New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. J Gastroenterol 49:755–763CrossRefPubMed
26.
go back to reference Kono Y, Lyshchik A, Cosgrove D et al (2017) Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®): the official version by the American College of Radiology (ACR). Ultraschall Med 38:85–86CrossRefPubMed Kono Y, Lyshchik A, Cosgrove D et al (2017) Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®): the official version by the American College of Radiology (ACR). Ultraschall Med 38:85–86CrossRefPubMed
27.
go back to reference Lu W, Tang H, Yang Z, Jiang K, Chen Y, Lu S (2019) Clinical predictors of small solitary hepatitis B virus-related hepatocellular carcinoma microinvasion. ANZ J Surg 89:E438–E442CrossRefPubMed Lu W, Tang H, Yang Z, Jiang K, Chen Y, Lu S (2019) Clinical predictors of small solitary hepatitis B virus-related hepatocellular carcinoma microinvasion. ANZ J Surg 89:E438–E442CrossRefPubMed
28.
go back to reference Lee S, Kang TW, Song KD et al (2021) Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg 273:564–571CrossRefPubMed Lee S, Kang TW, Song KD et al (2021) Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg 273:564–571CrossRefPubMed
29.
go back to reference Peng Z, Chen S, Xiao H et al (2019) Microvascular invasion as a predictor of response to treatment with sorafenib and transarterial chemoembolization for recurrent intermediate-stage hepatocellular carcinoma. Radiology 292:237–247CrossRefPubMed Peng Z, Chen S, Xiao H et al (2019) Microvascular invasion as a predictor of response to treatment with sorafenib and transarterial chemoembolization for recurrent intermediate-stage hepatocellular carcinoma. Radiology 292:237–247CrossRefPubMed
30.
go back to reference Wang P, Nie F, Dong T, Wang G, Wang L, Fan X (2022) Study on correlation between two-dimensional ultrasound, contrast-enhanced ultrasound and microvascular invasion in hepatocellular carcinoma. Clin Hemorheol Microcirc 80:97–106CrossRefPubMed Wang P, Nie F, Dong T, Wang G, Wang L, Fan X (2022) Study on correlation between two-dimensional ultrasound, contrast-enhanced ultrasound and microvascular invasion in hepatocellular carcinoma. Clin Hemorheol Microcirc 80:97–106CrossRefPubMed
31.
go back to reference Sugimori K, Numata K, Okada M et al (2017) Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US. J Med Ultrason 44:89–100CrossRef Sugimori K, Numata K, Okada M et al (2017) Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US. J Med Ultrason 44:89–100CrossRef
32.
go back to reference Zhou H, Zhang C, Du L et al (2022) Contrast-enhanced ultrasound liver imaging reporting and data system in diagnosing hepatocellular carcinoma: diagnostic performance and interobserver agreement. Ultraschall Med 43:64–71CrossRefPubMed Zhou H, Zhang C, Du L et al (2022) Contrast-enhanced ultrasound liver imaging reporting and data system in diagnosing hepatocellular carcinoma: diagnostic performance and interobserver agreement. Ultraschall Med 43:64–71CrossRefPubMed
33.
go back to reference Zhou H, Sun J, Jiang T et al (2021) A nomogram based on combining clinical features and contrast enhanced ultrasound Li-RADS improves prediction of microvascular invasion in hepatocellular carcinoma. Front Oncol 11:699290CrossRefPubMedPubMedCentral Zhou H, Sun J, Jiang T et al (2021) A nomogram based on combining clinical features and contrast enhanced ultrasound Li-RADS improves prediction of microvascular invasion in hepatocellular carcinoma. Front Oncol 11:699290CrossRefPubMedPubMedCentral
34.
go back to reference Kitao A, Zen Y, Matsui O, Gabata T, Nakanuma Y (2009) Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography-radiologic-pathologic correlation. Radiology 252:605–614CrossRefPubMed Kitao A, Zen Y, Matsui O, Gabata T, Nakanuma Y (2009) Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography-radiologic-pathologic correlation. Radiology 252:605–614CrossRefPubMed
35.
go back to reference Ünal E, İdilman İS, Akata D, Özmen MN, Karçaaltıncaba M (2016) Microvascular invasion in hepatocellular carcinoma. Diagn Interv Radiol 22:125–132CrossRefPubMedPubMedCentral Ünal E, İdilman İS, Akata D, Özmen MN, Karçaaltıncaba M (2016) Microvascular invasion in hepatocellular carcinoma. Diagn Interv Radiol 22:125–132CrossRefPubMedPubMedCentral
36.
go back to reference Hirokawa F, Hayashi M, Miyamoto Y et al (2014) Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma. Hepatol Res 44:846–853CrossRefPubMed Hirokawa F, Hayashi M, Miyamoto Y et al (2014) Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma. Hepatol Res 44:846–853CrossRefPubMed
37.
go back to reference He YZ, He K, Huang RQ et al (2020) Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis. Ann Hepatol 19:654–661CrossRefPubMed He YZ, He K, Huang RQ et al (2020) Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis. Ann Hepatol 19:654–661CrossRefPubMed
38.
go back to reference Zheng J, Chou JF, Gönen M et al (2017) Prediction of hepatocellular carcinoma recurrence beyond Milan criteria after resection: validation of a clinical risk score in an international cohort. Ann Surg 266:693–701CrossRefPubMed Zheng J, Chou JF, Gönen M et al (2017) Prediction of hepatocellular carcinoma recurrence beyond Milan criteria after resection: validation of a clinical risk score in an international cohort. Ann Surg 266:693–701CrossRefPubMed
39.
go back to reference Gozzo C, Hermida M, Herrero A et al (2022) Non-transplantable recurrence after percutaneous thermal ablation of ≤ 3-cm HCC: predictors and implications for treatment allocation. Hepatol Commun 6:2975–2987CrossRefPubMedPubMedCentral Gozzo C, Hermida M, Herrero A et al (2022) Non-transplantable recurrence after percutaneous thermal ablation of ≤ 3-cm HCC: predictors and implications for treatment allocation. Hepatol Commun 6:2975–2987CrossRefPubMedPubMedCentral
Metadata
Title
Value of high frame rate contrast-enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma
Authors
Xiang Fei
Lianhua Zhu
Peng Han
Bo Jiang
Miao Li
Nan Li
Ziyu Jiao
Dirk-André Clevert
Yukun Luo
Publication date
01-12-2024
Publisher
Springer Vienna
Published in
Insights into Imaging / Issue 1/2024
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-024-01821-6